Hemolysis [hemolýza]

topical
386
Terms

extravaskulární hemolýza
intravaskulární hemolýza

 

Extravascular Hemolysis
Haemolysis
Intravascular Hemolysis

Persistent link   https://www.medvik.cz/link/D006461
Definition

The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Annotation
hemolysis in gel = HEMOLYTIC PLAQUE TECHNIQUE
DUI
D006461 MeSH Browser
CUI
M0010143

Allowable subheadings

DE
drug effects 60
ES
ethics
GE
genetics 11
IM
immunology 12
PH
physiology 20
RE
radiation effects 3

C Diseases
C23 Pathological Conditions, Signs and Symptoms 451
C23.550 Pathologic Processes 195
C23.550.035 Acantholysis 10
C23.550.073 Arrhythmias, Cardiac 2 815
C23.550.081 Ascites 336
C23.550.113 Atrial Remodeling 13
C23.550.145 Azotemia 5
C23.550.161 Cardiotoxicity 143
C23.550.177 Channelopathies 14
C23.550.210 Chromosome Aberrations 1 579
C23.550.260 Death 1 413
C23.550.274 Dehydration 403
C23.550.277 Delayed Graft Function 25
C23.550.288 Disease 1 716
C23.550.291 Disease Attributes 1 208
C23.550.308 Dysbiosis 109
C23.550.325 Emphysema 89
C23.550.340 Extravasation of Diagnostic and Therapeutic Materials 36
C23.550.347 Femoracetabular Impingement 27
C23.550.355 Fibrosis 368
C23.550.359 Frailty 125
C23.550.362 Genomic Instability 90
C23.550.369 Gliosis 38
C23.550.382 Granuloma 236
C23.550.384 Granulomatosis, Orofacial 6
C23.550.393 Growth Disorders 641
C23.550.403 Hemolysis 386
C23.550.414 Hemorrhage 2 304
C23.550.421 Hyperammonemia 31
C23.550.425 Hyperamylasemia 5
C23.550.429 Hyperbilirubinemia 185
C23.550.444 Hyperplasia 340
C23.550.449 Hyperuricemia 228
C23.550.455 Hypovolemia 88
C23.550.470 Inflammation 3 499
C23.550.505 Intraoperative Complications 719
C23.550.513 Ischemia 1 735
C23.550.522 Leukoaraiosis 4
C23.550.526 Leukocytosis 100
C23.550.537 Lithiasis 87
C23.550.543 Long Term Adverse Effects 7
C23.550.548 Malacoplakia 4
C23.550.568 Menstruation Disturbances 353
C23.550.589 Metaplasia 98
C23.550.695 Muscle Weakness 226
C23.550.706 Myotoxicity 1
C23.550.717 Necrosis 840
C23.550.722 Neointima 8
C23.550.727 Neoplastic Processes 131
C23.550.737 Nerve Degeneration 167
C23.550.744 Ochronosis 42
C23.550.751 Ossification, Heterotopic 140
C23.550.753 Ototoxicity 11
C23.550.755 Pigmentation Disorders 132
C23.550.759 Polydipsia 18
C23.550.767 Postoperative Complications 7 117
C23.550.770 Protein Aggregation, Pathological 17
C23.550.773 Respiratory Aspiration 79
C23.550.794 Retropneumoperitoneum 14
C23.550.823 Sclerosis 84
C23.550.835 Shock 411
C23.550.863 Teratogenesis 28
C23.550.877 Toxic Optic Neuropathy 1
C23.550.891 Ulcer 201
C23.550.918 Vascular Remodeling 30
C23.550.945 Yang Deficiency 9
C23.550.972 Yin Deficiency 9

G Phenomena and Processes
G12 Immune System Phenomena 249
G12.122 Antigen-Antibody Reactions 393
G12.122.100 Agglutination 53
G12.122.125 Antibody Affinity 39
G12.122.140 Antigenic Modulation 11
G12.122.232 Binding Sites, Antibody 28
G12.122.281 Cross Reactions 190
G12.122.545 Hemolysis 386
G12.122.612 Immunologic Capping 1
G12.122.754 Passive Cutaneous Anaphylaxis 8
G12.122.780 Rh Isoimmunization 82

Red cell phospholipid defect with hemolysis Disease MeSH Browser

Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis Disease MeSH Browser

Add